Understanding the cellular interactome of non-alcoholic fatty liver disease

Asrani, 2019, Burden of liver diseases in the world, J Hepatol, 70, 151, 10.1016/j.jhep.2018.09.014 Karlsen, 2022, The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality, Lancet, 399, 61, 10.1016/S0140-6736(21)01701-3 British Liver trust. Statistical report. https://britishlivertrust.org.uk/. Accessed 07/11/21. Asrani, 2013, Underestimation of liver-related mortality in the United States, Gastroenterology, 145, 375, 10.1053/j.gastro.2013.04.005 Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Williams, 2011, Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study, Gastroenterology, 140, 124, 10.1053/j.gastro.2010.09.038 Torok, 2015, Strategies and endpoints of antifibrotic drug trials, Hepatology, 62, 627, 10.1002/hep.27720 Schuppan, 2008, Liver cirrhosis, Lancet, 371, 838, 10.1016/S0140-6736(08)60383-9 Sanyal, 2010, Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis, N Engl J Med, 362, 1675, 10.1056/NEJMoa0907929 Vuppalanchi, 2021, Therapeutic pipeline in nonalcoholic steatohepatitis, Nat Rev Gastroenterol Hepatol, 18, 373, 10.1038/s41575-020-00408-y Friedman, 2015, Hepatic fibrosis: concept to treatment, J Hepatol, 62, S15, 10.1016/j.jhep.2015.02.039 Eming, 2017, Inflammation and metabolism in tissue repair and regeneration, Science, 356, 1026, 10.1126/science.aam7928 Schuppan, 2013, Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches, J Gastroenterol Hepatol, 28, 68, 10.1111/jgh.12212 Pingitore, 2019, Human multilineage 3D spheroids as a model of liver steatosis and fibrosis, Int J Mol Sci, 20, 1629, 10.3390/ijms20071629 Hassan, 2020, Liver-on-a-Chip models of fatty liver disease, Hepatology, 71, 733, 10.1002/hep.31106 Armingol, 2021, Deciphering cell-cell interactions and communication from gene expression, Nat Rev Genet, 22, 71, 10.1038/s41576-020-00292-x Garcia-Alonso, 2021, Mapping the temporal and spatial dynamics of the human endometrium in vivo and in vitro, Nat Genet, 53, 1698, 10.1038/s41588-021-00972-2 Wang, 2021, Dissecting the single-cell transcriptomeunderlying chronic liver injury, Mol Ther Nucleic Acids, 26, 1364, 10.1016/j.omtn.2021.11.008 Wang, 2021, Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis, Sci Rep, 11 Xiong, 2019, Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis, Mol Cell, 75, 644, 10.1016/j.molcel.2019.07.028 Ouchi, 2019, Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids, Cell Metab, 30, 374, 10.1016/j.cmet.2019.05.007 Deng, 2019, Engineered liver-on-a-chip platform to mimic liver functions and its biomedical applications: a review, Micromachines (Basel), 10, 676, 10.3390/mi10100676 Ibrahim, 2018, Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation, Gut, 67, 963, 10.1136/gutjnl-2017-315691 Begriche, 2013, Mitochondrial adaptations and dysfunctions in NAFLD, Hepatology, 58, 1497, 10.1002/hep.26226 Wisely, 2002, Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids, Structure, 10, 1225, 10.1016/S0969-2126(02)00829-8 Yin, 2015, Glucose fluctuation increased hepatocyte apoptosis under lipotoxicity and the involvement of mitochondrial permeability transition opening, J Mol Endocrinol, 55, 169, 10.1530/JME-15-0101 Miura, 2014, Role of gut microbiota and Toll-like receptors in NAFLD, World J Gastroenterol, 20, 7381, 10.3748/wjg.v20.i23.7381 Zhu, 2021, Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis, Nat Rev Gastroenterol Hepatol, 18, 131, 10.1038/s41575-020-00365-6 Zhu, 2018, Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis, Sci Transl Med, 10, 10.1126/scitranslmed.aat0344 Wang, 2016, Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis, Cell Metab, 24, 848, 10.1016/j.cmet.2016.09.016 Rockey, 2015, Fibrosis–a common pathway to organ injury and failure, N Engl J Med, 372, 1138, 10.1056/NEJMra1300575 Fallowfield, 2015, Future mechanistic strategies for tackling fibrosis–an unmet need in liver disease, Clin Med (Lond), 15, s83, 10.7861/clinmedicine.15-6-s83 Schwabe, 2018, Apoptosis and necroptosis in the liver: a matter of life and death, Nat Rev Gastroenterol Hepatol, 15, 738, 10.1038/s41575-018-0065-y Gong, 2020, DAMP-sensing receptors in sterile inflammation and inflammatory diseases, Nat Rev Immunol, 20, 95, 10.1038/s41577-019-0215-7 Alegre, 2017, Inflammasomes in liver fibrosis, Semin Liver Dis, 37, 119, 10.1055/s-0037-1601350 Feng, 2020, Activation of NLRP3 inflammasome in hepatocytes after exposure to cobalt nanoparticles: the role of oxidative stress, Toxicol In Vitro, 69, 10.1016/j.tiv.2020.104967 Ibrahim, 2016, Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes [published correction appears in Hepatology. 2016 Aug;64(2):702], Hepatology, 63, 731, 10.1002/hep.28252 Rangwala, 2011, Increased production of sonic hedgehog by ballooned hepatocytes, J Pathol, 224, 401, 10.1002/path.2888 Swiderska-Syn, 2014, Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy, Gut, 63, 1333, 10.1136/gutjnl-2013-305962 Guy, 2015, Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity, Hepatology, 61, 98, 10.1002/hep.27235 Dobie, 2019, Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis, Cell Rep, 29, 1832, 10.1016/j.celrep.2019.10.024 Zhan, 2006, Phagocytosis of apoptotic bodies by HSCs induces NADPH oxidase and is associated with liver fibrosis in vivo, Hepatology, 43, 435, 10.1002/hep.21093 Liu, 2019, Cells exhibiting strong p16INK4a promoter activation in vivo display features of senescence, Proc Natl Acad Sci U S A, 116, 2603, 10.1073/pnas.1818313116 Ogrodnik, 2017, Cellular senescence drives age-dependent hepatic steatosis, Nat Commun, 8, 10.1038/ncomms15691 Engelmann, 2022, The potential role of cellular senescence in non-alcoholic fatty liver disease, Int J Mol Sci, 23, 652, 10.3390/ijms23020652 Irvine, 2014, Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration, World J Gastroenterol, 20, 17851, 10.3748/wjg.v20.i47.17851 Huda, 2019, Hepatic senescence, the good and the bad, World J Gastroenterol, 25, 5069, 10.3748/wjg.v25.i34.5069 Mederacke, 2022, The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver, Sci Transl Med, 14, 10.1126/scitranslmed.abe5795 Sato, 2019, Ductular reaction in liver diseases: pathological mechanisms and translational significances, Hepatology, 69, 420, 10.1002/hep.30150 Cordero-Espinoza, 2021, Dynamic cell contacts between periportal mesenchyme and ductal epithelium act as a rheostat for liver cell proliferation, Cell Stem Cell, 28, 1907, 10.1016/j.stem.2021.07.002 Michelotti, 2016, Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches, Gut, 65, 683, 10.1136/gutjnl-2014-308176 Richardson, 2007, Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction, Gastroenterology, 133, 80, 10.1053/j.gastro.2007.05.012 Gadd, 2014, The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease, Hepatology, 59, 1393, 10.1002/hep.26937 Pinzani, 1996, Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis, Am J Pathol, 148, 785 Milani, 1991, Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease, Am J Pathol, 139, 1221 Omenetti, 2008, Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans, J Clin Invest, 118, 3331 Schuppan, 2018, Determinants of fibrosis progression and regression in NASH, J Hepatol, 68, 238, 10.1016/j.jhep.2017.11.012 Peng, 2016, Integrin avb6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis, Hepatology, 63, 217, 10.1002/hep.28274 Henderson, 2013, Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs, Nat Med, 19, 1617, 10.1038/nm.3282 Reed, 2015, The αvβ1 integrin plays a critical in vivo role in tissue fibrosis, Sci Transl Med, 7, 288ra79, 10.1126/scitranslmed.aaa5094 Andrews, 2022, Single-cell, single-nucleus, and spatial RNA sequencing of the human liver identifies cholangiocyte and mesenchymal heterogeneity, Hepatol Commun, 6, 821, 10.1002/hep4.1854 Wen, 2021, Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities, Cell Mol Immunol, 18, 45, 10.1038/s41423-020-00558-8 Ramachandran, 2012, Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis, Proc Natl Acad Sci U S A, 109, E3186, 10.1073/pnas.1119964109 Brenner, 2013, Decoding cell death signals in liver inflammation, J Hepatol, 59, 583, 10.1016/j.jhep.2013.03.033 Tosello-Trampont, 2012, Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production, J Biol Chem, 287, 40161, 10.1074/jbc.M112.417014 Song, 2020, Yes-associated protein in kupffer cells enhances the production of proinflammatory cytokines and promotes the development of nonalcoholic steatohepatitis, Hepatology, 72, 72, 10.1002/hep.30990 Pan, 2018, Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release, Cell Immunol, 332, 111, 10.1016/j.cellimm.2018.08.006 Minutti, 2019, A macrophage-pericyte axis directs tissue restoration via amphiregulin-induced transforming growth factor beta activation, Immunity, 50, 645, 10.1016/j.immuni.2019.01.008 Krenkel, 2018, Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis, Hepatology, 67, 1270, 10.1002/hep.29544 Karlmark, 2009, Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis, Hepatology, 50, 261, 10.1002/hep.22950 Pellicoro, 2014, Liver fibrosis and repair: immune regulation of wound healing in a solid organ, Nat Rev Immunol, 14, 181, 10.1038/nri3623 Krenkel, 2020, Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis, Gut, 69, 551, 10.1136/gutjnl-2019-318382 Jaitin, 2019, Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner, Cell, 178, 686, 10.1016/j.cell.2019.05.054 Lefere, 2019, Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism, JHEP Rep, 1, 30, 10.1016/j.jhepr.2019.02.004 Ramachandran, 2019, Resolving the fibrotic niche of human liver cirrhosis at single-cell level, Nature, 575, 512, 10.1038/s41586-019-1631-3 Seidman, 2020, Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis, Immunity, 52, 1057, 10.1016/j.immuni.2020.04.001 Blériot, 2021, A subset of Kupffer cells regulates metabolism through the expression of CD36, Immunity, 54, 2101, 10.1016/j.immuni.2021.08.006 Guilliams, 2022, Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches, Cell, 185, 379, 10.1016/j.cell.2021.12.018 Haas, 2019, Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution, Nat Metab, 1, 604, 10.1038/s42255-019-0076-1 Henning, 2013, Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice, Hepatology, 58, 589, 10.1002/hep.26267 Deczkowska, 2021, XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis, Nat Med, 27, 1043, 10.1038/s41591-021-01344-3 Heier, 2017, Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis, J Hepatol, 66, 1241, 10.1016/j.jhep.2017.01.008 Radaeva, 2006, Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners, Gastroenterology, 130, 435, 10.1053/j.gastro.2005.10.055 Vivier, 2008, Functions of natural killer cells, Nat Immunol, 9, 503, 10.1038/ni1582 Stiglund, 2019, Retained NK cell phenotype and functionality in non-alcoholic fatty liver disease, Front Immunol, 10, 1255, 10.3389/fimmu.2019.01255 Tosello-Trampont, 2016, NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice, Hepatology, 63, 799, 10.1002/hep.28389 McHedlidze, 2013, Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis, Immunity, 39, 357, 10.1016/j.immuni.2013.07.018 Gao, 2016, IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis, Oncotarget, 7, 33649, 10.18632/oncotarget.9259 Tilg, 2020, A role for IL-1 inhibitors in the treatment of non-alcoholic fatty liver disease (NAFLD)?, Expert Opin Investig Drugs, 29, 103, 10.1080/13543784.2020.1681397 Hamaguchi, 2021, Group 3 innate lymphoid cells protect steatohepatitis from high-fat diet induced toxicity, Front Immunol, 12, 10.3389/fimmu.2021.648754 Kong, 2012, Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice, Hepatology, 56, 1150, 10.1002/hep.25744 Syn, 2010, Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease, Hepatology, 51, 1998, 10.1002/hep.23599 Wolf, 2014, Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes, Cancer Cell, 26, 549, 10.1016/j.ccell.2014.09.003 Wehr, 2013, Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis, J Immunol, 190, 5226, 10.4049/jimmunol.1202909 Hegde, 2018, Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver, Nat Commun, 9, 2146, 10.1038/s41467-018-04450-y Li, 2018, Mucosal-associated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization, Front Immunol, 9, 1994, 10.3389/fimmu.2018.01994 Li, 2017, The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner, Nat Commun, 7 Yoshida, 2014, Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice, Gastroenterology, 147, 1378, 10.1053/j.gastro.2014.08.038 Malehmir, 2019, Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer, Nat Med, 25, 641, 10.1038/s41591-019-0379-5 Alkhouri, 2012, Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease, Liver Int, 32, 297, 10.1111/j.1478-3231.2011.02639.x Narayanan, 2016, The immune landscape in nonalcoholic steatohepatitis, Immune Netw, 16, 147, 10.4110/in.2016.16.3.147 Rensen, 2012, Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice, PLoS One, 7, 10.1371/journal.pone.0052411 Fabre, 2014, IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-β receptor on hepatic stellate cells in a JNK-dependent manner, J Immunol, 193, 3925, 10.4049/jimmunol.1400861 Wree, 2018, NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice, Hepatology, 67, 736, 10.1002/hep.29523 Koo, 2020, Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma, Exp Mol Med, 52, 1209, 10.1038/s12276-020-0480-3 Dudek, 2021, Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH, Nature, 592, 444, 10.1038/s41586-021-03233-8 Tang, 2011, Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease, Clin Exp Immunol, 166, 281, 10.1111/j.1365-2249.2011.04471.x Bhattacharjee, 2014, Role of immunodeficient animal models in the development of fructose induced NAFLD, J Nutr Biochem, 25, 219, 10.1016/j.jnutbio.2013.10.010 Sutti, 2014, Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH, Hepatology, 59, 886, 10.1002/hep.26749 Barrow, 2021, The emerging role of B cells in the pathogenesis of NAFLD, Hepatology, 74, 2277, 10.1002/hep.31889 Barrow, 2021, Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling, Hepatology, 74, 704, 10.1002/hep.31755 Hutchison, 2013, Resident mesenchymal cells and fibrosis, Biochim Biophys Acta, 1832, 962, 10.1016/j.bbadis.2012.11.015 Mederacke, 2013, Fate tracing reveals HSCs as dominant contributors to liver fibrosis independent of its aetiology, Nat Commun, 4, 2823, 10.1038/ncomms3823 Schwabe, 2020, Mechanisms of fibrosis development in nonalcoholic steatohepatitis, Gastroenterology, 158, 1913, 10.1053/j.gastro.2019.11.311 Hinz, 2012, Recent developments in myofibroblast biology: paradigms for connective tissue remodeling, Am J Pathol, 180, 1340, 10.1016/j.ajpath.2012.02.004 Breitkopf, 2006, TGF-beta/Smad signaling in the injured liver, Z Gastroenterol, 44, 57 Lindsey, 2016, Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling, J Mol Cell Cardiol, 91, 134, 10.1016/j.yjmcc.2015.12.018 Sahin, 2010, Functional role of chemokines in liver disease models, Nat Rev Gastroenterol Hepatol, 7, 682, 10.1038/nrgastro.2010.168 Schwabe, 2003, Human HSCs express CCR5 and RANTES to induce proliferation and migration, Am J Physiol Gastrointest Liver Physiol, 285, G949, 10.1152/ajpgi.00215.2003 Pradere, 2013, Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated HSCs in mice, Hepatology, 58, 1461, 10.1002/hep.26429 Meyer, 1990, Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha, Biochem Biophys Res Commun, 171, 1122, 10.1016/0006-291X(90)90801-S Win, 1993, Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor, Hepatology, 18, 137, 10.1002/hep.1840180121 Marra, 1995, Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: potential role in liver injury, Hepatology, 22, 780 Steiling, 2004, Activated HSCs express keratinocyte growth factor in chronic liver disease, Am J Pathol, 165, 1233, 10.1016/S0002-9440(10)63383-4 Yu, 2003, Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis, Am J Pathol, 163, 1653, 10.1016/S0002-9440(10)63522-5 Seki, 2007, TLR4 enhances TGF-beta signaling and hepatic fibrosis, Nat Med, 13, 1324, 10.1038/nm1663 Mann, 2009, Transcriptional regulation of HSCs, Adv Drug Deliv Rev, 61, 497, 10.1016/j.addr.2009.03.011 Wang, 2016, Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in non alcoholic steatohepatitis, Cell Metab, 24, 848, 10.1016/j.cmet.2016.09.016 Zhu, 2018, Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis, Sci Transl Med, 10, 10.1126/scitranslmed.aat0344 Krenkel, 2019, Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis, Cells, 8, 503, 10.3390/cells8050503 Rosenthal, 2021, Heterogeneity of HSCs in a mouse model of NASH, Hepatology, 74, 667, 10.1002/hep.31743 MacParland, 2018, Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations, Nat Commun, 9, 4383, 10.1038/s41467-018-06318-7 Dranoff, 2010, Portal fibroblasts: underappreciated mediators of biliary fibrosis, Hepatology, 51, 1438, 10.1002/hep.23405 Yang, 2021, Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis in mice, Hepatology, 74, 2774, 10.1002/hep.31987 Katsumata, 2017, Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury, Hepatol Commun, 1, 198, 10.1002/hep4.1023 Wells, 2015, Origin and function of myofibroblasts in the liver, Semin Liver Dis, 35, 97, 10.1055/s-0035-1550061 Lei, 2022, Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis, Hepatology Tateya, 2011, Endothelial NO/cGMP/VASP signalling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding, Diabetes, 60, 2792, 10.2337/db11-0255 Shetty, 2018, Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity, Nat Rev Gastroenterol Hepatol, 15, 555, 10.1038/s41575-018-0020-y McMahan, 2016, Free fatty acids differentially downregulate chemokines in liver sinusoidal endothelial cells: insights into non-alcoholic fatty liver disease, PLoS One, 11, 10.1371/journal.pone.0159217 Canton, 2013, Scavenger receptors in homeostasis and immunity, Nat Rev Immunol, 13, 621, 10.1038/nri3515 Cogger, 2016, Dietary macronutrients and the aging liver sinusoidal endothelial cell, Am J Physiol Heart Circ Physiol, 310, H1064, 10.1152/ajpheart.00949.2015 Ding, 2014, Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis, Nature, 505, 97, 10.1038/nature12681 Halpern, 2017, Single-cell spatial reconstruction reveals global division of labour in the mammalian liver, Nature, 542, 352, 10.1038/nature21065 Su, 2021, Single-cell transcriptomics reveals zone-specific alterations of liver sinusoidal endothelial cells in cirrhosis, Cell Mol Gastroenterol Hepatol, 11, 1139, 10.1016/j.jcmgh.2020.12.007 Gola, 2021, Commensal-driven immune zonation of the liver promotes host defence, Nature, 589, 131, 10.1038/s41586-020-2977-2 García-Lezana, 2018, Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis, Hepatology, 67, 1485, 10.1002/hep.29646 Otte, 2003, Intestinal myofibroblasts in innate immune responses of the intestine, Gastroenterology, 124, 1866, 10.1016/S0016-5085(03)00403-7 Jia, 2014, Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance, Nat Commun, 5, 3878, 10.1038/ncomms4878 Yu, 2021, Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis, Sci Transl Med, 13, 10.1126/scitranslmed.abe1692 Seki, 2007, TLR4 enhances TGF-beta signaling and hepatic fibrosis, Nat Med, 13, 1324, 10.1038/nm1663 Seki, 2008, Toll-like receptors and adaptor molecules in liver disease: update, Hepatology, 48, 322, 10.1002/hep.22306 Yang, 2017, TRIF differentially regulates hepatic steatosis and inflammation/fibrosis in mice, Cell Mol Gastroenterol Hepatol, 3, 469, 10.1016/j.jcmgh.2016.12.004 Hernandez, 2020, Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH, Am J Physiol Gastrointest Liver Physiol, 318, G582, 10.1152/ajpgi.00344.2019 Kirita, 2020, Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury, Proc Natl Acad Sci U S A, 117, 15874, 10.1073/pnas.2005477117 Kuppe, 2021, Decoding myofibroblast origins in human kidney fibrosis, Nature, 589, 281, 10.1038/s41586-020-2941-1 Wang, 2009, Kupffer cells mediate leptin-induced liver fibrosis, Gastroenterology, 137, 713, 10.1053/j.gastro.2009.04.011 Saxena, 2002, Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice, Hepatology, 35, 762, 10.1053/jhep.2002.32029 Lefere, 2020, Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆, J Hepatol, 73, 757, 10.1016/j.jhep.2020.04.025 Garrido, 2021, Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis, J Hepatol, 25 Shi, 2021, TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation, Front Immunol, 11, 10.3389/fimmu.2020.609060 Rau, 2018, Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease, United Eur Gastroenterol J, 6, 1496, 10.1177/2050640618804444 Younossi, 2019, REGENERATE Study Investigators. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial, Lancet, 394, 2184, 10.1016/S0140-6736(19)33041-7 Rogliani, 2016, Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis, Pulm Pharmacol Ther, 40, 95, 10.1016/j.pupt.2016.07.009 Cao, 2018, Joint profiling of chromatin accessibility and gene expression in thousands of single cells, Science, 361, 1380, 10.1126/science.aau0730 Peterson, 2017, Multiplexed quantification of proteins and transcripts in single cells, Nat Biotechnol, 35, 936, 10.1038/nbt.3973 Vickovic, 2019, High-definition spatial transcriptomics for in situ tissue profiling, Nat Methods, 16, 987, 10.1038/s41592-019-0548-y Efremova, 2020, CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand-receptor complexes, Nat Protoc, 15, 1484, 10.1038/s41596-020-0292-x Browaeys, 2020, NicheNet: modeling intercellular communication by linking ligands to target genes, Nat Methods, 17, 159, 10.1038/s41592-019-0667-5 Schraivogel, 2020, Targeted Perturb-seq enables genome-scale genetic screens in single cells, Nat Methods, 17, 629, 10.1038/s41592-020-0837-5 Regev, 2017, Human cell atlas meeting participants. The human cell atlas, Elife, 6